100m customers is the new $HIMS target. Likely raised because peptide approval is lingering. Also, 90% of people are left untreated for certain conditions.
In 2000, investors paid 130x earnings for Cisco and 17x for consumer staples.
Today, they pay 4x for Micron and 40x for Walmart.
Read that again.
We're in the middle of potentially the largest AI infrastructure buildout in history, and Wall Street is paying 10 TIMES the earnings multiple for Walmart versus Micron.
In 2000, investors were terrified of missing the future.
In 2026, they're terrified of owning it.
The greatest risk in 2000 was paying too much for the future.
What if the greatest risk in 2026 is paying too much to avoid it?
100m customers is the new $HIMS target. Likely raised because peptide approval is lingering. Also, 90% of people are left untreated for certain conditions.
@mk12856907@growthrapidly BPC, GLP-1, supplements, hair sprays, labs, wearables. It’s a massive ecosystem and people don’t know it yet. But their health will improve >2x with a $HIMS subscription once the full system is built out.
$HIMS is the $COST of healthcare. And can scale faster because it is online. $500b MC sounds crazy, but it is possible because of the value ecosystem they are creating.
Profit won’t come in high margin peptides, labs, GLP-1, etc- but a yearly subscription to 100m+ customers.